SICAGEN INDIA LTD. - 533014 - Board recommends Dividend
Sicagen India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 17, 2020, inter alia, has considered and recommended equity dividend @ 5% (50 paise per share) for the financial year 2019-20, subject to the approval of shareholders in the ensuing Annual General Meeting. SICAGEN INDIA LTD. - 533014 - Submission Of Audited Financial Results For The Quarter And Year Ended 31 Mar 2020
This is to inform that the Board of Directors of the Company at their meeting held today, has inter alia considered and approved the audited financial results (both standalone & consolidated results) of the Company for the quarter and year ended 31st March 2020. The Board has also considered and recommended equity dividend @ 5% (50 paise per share) for the financial year 2019-20, subject to the approval of shareholders in the ensuing Annual General Meeting. Pursuant to Regulation 33 of the SEBI (LODR) Regulation 2015, copies of the aforesaid financial results are herewith attached. SICAGEN INDIA LTD. - 533014 - Board to consider Dividend
Sicagen India Ltd has informed BSE that the meeting of the Board of Directors of the Company has been scheduled to be held on June 17, 2020, inter alia, to consider the following :-1. Audited annual accounts of the Company for the year ended March 31, 2020.2. Audited financial results (standalone & consolidated results) for the quarter and year ended March 31, 2020.3. Recommendation of equity dividend if any considered for the financial year 2019-20. SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended 31St Mar 2020.
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/06/2020 ,inter alia, to consider and approve - Audited annual accounts of the Company for the year ended 31st March 2020. - Audited financial results (standalone & consolidated results) for the quarter and year ended 31st March 2020. - Recommendation of equity dividend, if any, considered for the financial year 2019-20. SICAGEN INDIA LTD. - 533014 - Clarification sought from Sicagen India Ltd
The Exchange has sought clarification from Sicagen India Ltd on June 08, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. SICAGEN INDIA LTD. - 533014 - Compliance Certificate Under Reg 40 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 31 Mar'' 2020
We herewith submit the Compliance Certificate issued by Mr.R.Kannan, Practicing Company Secretary for the quarter ended 31 March 2020 as required Reg 40(10) of SEBI (LODR) Regulations, 2015. SICAGEN INDIA LTD. - 533014 - Shareholding for the Period Ended March 31, 2020
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here SICAGEN INDIA LTD. - 533014 - Compliance Certificate Under Reg 7(3)
We herewith submit the Compliance Certificate for the half year ended 31.03.2020 as required under Reg 7(3) of SEBI LODR Regulations,2015. SICAGEN INDIA LTD. - 533014 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- G ArunmozhiDesignation :- Company Secretary and Compliance Officer